Siemens Healthineers Ag Stock News

Siemens Healthineers AG (OTCPK:SEMHF) Q3 2022 Earnings Conference Call August 3, 2022 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernhard Montag - President, CEO & Chairman Jochen Schm

U.S.-German medical device maker Siemens Healthineers stuck with its outlook for the 2022 financial year on Wednesday as supply-chain headwinds and COVID-19 lock-downs pushed some sales into next quar

Siemens Healthineers AG is a subsidiary of Siemens AG and a leading medical technology company. The company designs, develops, manufactures and markets sophisticated healthcare solutions for a broad r

Siemens Healthineers AG (OTCPK:SEMHF) Q2 2022 Earnings Conference Call May 4, 2022 2:00 AM ET Company Participants Marc Koebernick - IR Bernd Montag - CEO Jochen Schmitz - CFO Conference Call Particip

U.S.-German medical device maker Siemens Healthineers raised its 2022 targets on Wednesday due to increased demand for rapid COVID-19 antigen tests, and reported a rise in first-quarter revenue and ea

WASHINGTON, March 11, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Heart Failure POC & LOC Devices Market finds that factors such as, increasing geriatric population base, growing research & development activities and rising cardiovascular diseases are augmenting the growth of Heart Failure POC & LOC Devices Market in upcoming time span. The total Global Heart Failure POC & LOC Devices Market is estimated to reach USD 180.1 Million by 2028. The Market stood at a revenue of USD 55.9 Million in the year 2021, and is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 16.5%, states Vantage Market Research, in a report, titled " Heart Failure POC & LOC Devices Market by Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), by Technology (Microfluidics, Array-based Systems, Others), by End Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

In this article, we're looking at the German company Siemens, an industrial conglomerate that once had a corporate structure similar to General Electric.

New York, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Countries'' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031" - https://www.reportlinker.com/p06135349/?utm_source=GNW Market Segmentation • Product - Conventional Technologies (Endoscopes and Endoscopic Systems, Video and Visualization Systems, Capsule Endoscopy, Instruments and Accessories, Others), Surgical Robotics (Robotic Systems, Instruments and Accessories, Services) • Application - General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Others • End User - Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics • Region - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa Regional Segmentation • North America - U.S., Canada • Europe - Germany, France, Spain, U.

WASHINGTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Prostate Specific Antigen (PSA) Testing Market finds that rising prostate cancer among men, who are over 50 years in age is augmenting the growth of Prostate Specific Antigen (PSA) Testing Market in the coming years. In addition, various inventions for the diagnosis of prostate cancer and development of various assay-based methods have increased the demand for PSA testing. This improved technology is used to provide accuracy and specificity of the results, thus, helps in improving the Prostate Specific Antigen (PSA) Testing Market demand. The total Global Prostate Specific Antigen (PSA) Testing Market is estimated to reach USD 5.83 Billion by 2028. The market stood at a revenue of USD 3.12 Billion in 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 11.2%, states Vantage Market Research, in a report, titled " Prostate Specific Antigen (PSA) Testing Market by Test Type (Preliminary Tests, Confirmatory Tests), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Smith & Nephew (SNN) appointed Deepak Nath as CEO, effective April 1, succeeding Roland Diggelmann, who will step down by mutual agreement on March 31.Nath joins Smith+Nephew from

(Reuters) Smith+Nephew named Siemens Healthineers executive Deepak Nath as its new boss on Tuesday after the medical products maker narrowly missed analysts estimate for annual profit, weighed down by supply issues and the pandemic.

Fiscal first quarter results were boosted by strong contributions from rapid antigen testing, but mixed core results were still better than peer results. The Imaging business looks poised to go from s

LONDON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company''s research report on the medical equipment maintenance market, the increase in demand for medical devices is significantly contributing to the growth of the medical equipment maintenance market. Medical devices are instruments, machines, and apparatus that are used for medical purposes to prevent, diagnose, or treat diseases. The rising demand for medical devices requires effective medical equipment maintenance services to lower dispatch costs, minimize patient dissatisfaction, ensure prompt patient treatment, and lower fatality and risk during patient care. For instance, according to the International Trade Administration and U.S. Department of Commerce reports, the total production of medical devices and equipment in India reached $4.4 billion in 2020, which is an increase from $2.3 billion in 2019. Therefore, the increase in demand for medical devices is expected to propel the growth of the medical equipment maintenance market.

Las Vegas, USA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Molecular Diagnostics Market is Expected to Grow at a Substantial CAGR of 9.21% and is Contemplated to Reach USD 16.12 Billion by 2026, Estimates DelveInsight Molecular Diagnostics Market is contemplated to witness huge demand in the upcoming years due to rising infectious diseases and their diagnosis, the presence of global as well as regional manufacturers active in developing the Molecular Diagnostic products such as Qiagen, Roche, Molbio Diagnostics Pvt. Ltd., among others. Also, improving healthcare infrastructure, government initiatives in raising awareness regarding molecular diagnosis will contribute to the Molecular Diagnostics market growth in these regions. DelveInsight''s Molecular Diagnostics Market Insights and Forecast report provides the current and forecast Molecular Diagnostics Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Molecular Diagnostics Market.